ESC Heart Fail 5(6):10351043 Lepore JJ, Olson E, Demopoulos L, Haws T, Fang Z, Barbour AM, Fossler M, Davila-Roman VG, Russell SD, Gropler RJ (2016) Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction
This dual anti-inflammatory action protects cellular structures from degradation and supports homeostatic recovery after trauma, surgery, or repetitive strain injuries
studied the role of the gut microbiome in pancreatic ductal adenocarcinoma (PDAC) growth by treating mice with antibiotics, which resulted in a significant increase in tumour burden
Emotional eaters revert to baseline on semaglutide after a year while external eaters keep losing (Yabe 2025)
Hebbandi Nanjundappa R, Sokke Umeshappa C, Geuking MB